Barnes, Geoffrey D. https://orcid.org/0000-0002-6532-8440
Sippola, Emily
Ranusch, Allison
Takamine, Linda
Lanham, Michael
Dorsch, Michael
Sales, Anne
Sussman, Jeremy
Funding for this research was provided by:
agency for healthcare research and quality (R18HS026874)
Article History
Received: 26 August 2021
Accepted: 20 January 2022
First Online: 2 February 2022
Change Date: 13 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s43058-023-00412-8
Declarations
:
: Regulatory approval was obtained from the Ann Arbor VA and University of Michigan institutional review boards. Verbal informed consent was obtained from each interviewee.
: Non-applicable
: Dr. Barnes discloses consulting fees from Pfizer/Bristol Myers Squibb and Janssen. Dr. Dorsch is supported by R18 HS026874 and R21 HS026322 from the Agency for Health Research and Quality, R01 AG062582 from the National Institutes of Health (NIH)/National Institute of Aging, and the American Health Association Health IT Research Network; has received honoraria from Janssen; and has received research funding from Bristol Myers Squibb/Pfizer and Amgen in the past 2 years. The other authors have no disclosures. The authors declare that Anne Sales is co-Editor-in-Chief of the journal.